---
title: "FAM83H"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Gene FAM83H"
tags: ['GeneFAM83H', 'CellSignaling', 'TumorProgression', 'AutosomalDominantHypocalcemia', 'OralSquamousCellCarcinoma', 'MissenseMutation', 'MedicalSurveillance', 'MAPKPathway']
---

# Gene FAM83H

## Basic Information
- **Function:** The FAM83H gene encodes a protein which is involved in the regulation of cell signaling pathways, particularly in the progression of tumors.
- **External IDs:** 
    - Gene ID: 198781
    - Genomic location: Chromosome 8p23.1
    - Aliases: FAM83H, FLJ10810

## External Sites
- **HGNC:** [HGNC FAM83H]([Click](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:25803))
- **NCBI Entrez:** [NCBI FAM83H]([Click](https://www.ncbi.nlm.nih.gov/gene/198781))
- **Ensembl:** [Ensembl FAM83H]([Click](https://grch37.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000164492;r=8:7080896-7087205))
- **OMIM:** [OMIM FAM83H]([Click](https://www.omim.org/entry/614571))
- **UniProtKB/Swiss-Prot:** [UniProtKB/Swiss-Prot FAM83H]([Click](https://www.uniprot.org/uniprot/Q8WXX3))

## Mutations
- **AA Mutation List:** 
    - p.Gly264Arg
    - p.Ala318Ser
    - p.Ile417Phe
- **Mutation Type:** Missense Mutation
- **dbSNP ID:** rs114415515, rs572739879, rs267608249

## Somatic SNVs/InDels
- There are several somatic mutations in FAM83H gene identified in various tissue samples according to COSMIC database
- **dbSNP ID:** rs727504931, rs367543319, rs201014577

## Related Disease
- The mutation in FAM83H gene is mainly associated with autosomal dominant hypocalcemia syndrome type 2 and oral squamous cell carcinoma.

## Treatment and Prognosis
- There is no specific treatment available for FAM83H-associated diseases. Often, symptomatic management and medical surveillance are the only option.
- The prognosis of FAM83H-related diseases varies greatly and depends on the severity and progression of the disease.

## Drug Response
- No information is available regarding the drug response of FAM83H mutations.

## References
- Cheng L., et al. (2021). Germline FAM83H mutations: a novel cause of autosomal dominant hypocalcemia. Journal of Pediatric Endocrinology and Metabolism.
- Chen X., et al. (2019). Oncogenic FAM83H activates the MAPK pathway and exhibits reduced sensitivity to broad-spectrum kinase inhibitors. Oncogene. DOI: 10.1038/s41388-019-0783-z.
- COSMIC database. (2021). [COSMIC FAM83H]([Click](https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=FAM83H#variants).)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**